|
GSEC expression profile based on
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Stage1-vs-Stage2 |
5.145559E-01 |
| Stage1-vs-Stage3 |
1.063454E-01 |
| Stage1-vs-Stage4 |
1.931818E-01 |
| Stage2-vs-Stage3 |
2.472991E-01 |
| Stage2-vs-Stage4 |
4.193569E-01 |
| Stage3-vs-Stage4 |
8.535269E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Caucasian-vs-AfricanAmerican |
<1E-12 |
| Caucasian-vs-Asian |
<1E-12 |
| AfricanAmerican-vs-Asian |
<1E-12 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Male-vs-Female |
7.553308E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.938977E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.452573E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.088781E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.199389E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.420366E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.146495E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Biphasic-vs-Epithelioid |
5.964298E-01 |
| Biphasic-vs-Diffuse malignant |
4.933530E-01 |
| Biphasic-vs-Sarcomatoid |
6.115646E-02 |
| Epithelioid-vs-Diffuse malignant |
6.804429E-01 |
| Epithelioid-vs-Sarcomatoid |
1.306077E-01 |
| Diffuse malignant-vs-Sarcomatoid |
1.374342E-01 |
|
|
